The groundbreaking success of Viagra undeniably revolutionized the drug landscape, but betting in companies strongly reliant on off-patent versions presents a complex picture. While early profits were impressive, the end of patents and the emergence of discounted alternatives have diminished the customer base. Consequently, a thorough assessment of